Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Hearing Implants - Medical Devices Pipeline Assessment, 2020

Published by GlobalData Product code 229189
Published Content info 75 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hearing Implants - Medical Devices Pipeline Assessment, 2020
Published: December 1, 2020 Content info: 75 Pages
Description

GlobalData's Medical Devices sector report, "Hearing Implants - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Hearing Implants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hearing implants are electronic devices implanted into the ear of a deaf or hard to hear person. These devices transmit sound from the ear to the brain. Cochlear implant, bone anchored hearing implants and middle ear implants have been tracked under this category.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hearing Implants under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hearing Implants and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hearing Implants under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME1099EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Hearing Implants Overview

3 Products under Development

  • 3.1 Hearing Implants - Pipeline Products by Stage of Development
  • 3.2 Hearing Implants - Pipeline Products by Segment
  • 3.3 Hearing Implants - Pipeline Products by Territory
  • 3.4 Hearing Implants - Pipeline Products by Regulatory Path
  • 3.5 Hearing Implants - Pipeline Products by Estimated Approval Date
  • 3.6 Hearing Implants - Ongoing Clinical Trials

4 Hearing Implants - Pipeline Products under Development by Companies

  • 4.1 Hearing Implants Companies - Pipeline Products by Stage of Development
  • 4.2 Hearing Implants - Pipeline Products by Stage of Development

5 Hearing Implants Companies and Product Overview

  • 5.1 Advanced Bionics LLC Company Overview
    • 5.1.1 Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 Auritec Pharmaceuticals Inc Company Overview
    • 5.2.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview
    • 5.3.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 Cochlear Ltd Company Overview
    • 5.4.1 Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Demant A/S Company Overview
    • 5.5.1 Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Ecole Polytechnique Federale de Lausanne Company Overview
    • 5.6.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Envoy Medical Corp Company Overview
    • 5.7.1 Envoy Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Hannover Medical School Company Overview
    • 5.8.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 Hemideina Solution Company Overview
    • 5.9.1 Hemideina Solution Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Huntington Medical Research Institutes Company Overview
    • 5.10.1 Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 iotaMotion Inc Company Overview
    • 5.11.1 iotaMotion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Labyrinth Devices Company Overview
    • 5.12.1 Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 MED-EL Elektromedizinische Gerate Gesellschaft mbH Company Overview
    • 5.13.1 MED-EL Elektromedizinische Gerate Gesellschaft mbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Northwestern University Company Overview
    • 5.14.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 Oticon Medical AB Company Overview
    • 5.15.1 Oticon Medical AB Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 OtoKinetics Inc Company Overview
    • 5.16.1 OtoKinetics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Ototronix, LLC Company Overview
    • 5.17.1 Ototronix, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 Sonova Holding AG Company Overview
    • 5.18.1 Sonova Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 SpecialtyCare Inc Company Overview
    • 5.19.1 SpecialtyCare Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 Tel Aviv Sourasky Medical Center Company Overview
    • 5.20.1 Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 The University of Nottingham Company Overview
    • 5.21.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Trinity College Dublin Company Overview
    • 5.22.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 University of Florida Company Overview
    • 5.23.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 University of Michigan Pediatric Device Consortium Company Overview
    • 5.24.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 University of Oklahoma Company Overview
    • 5.25.1 University of Oklahoma Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 University of South Florida Company Overview
    • 5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 University of Utah Company Overview
    • 5.27.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 University of Wisconsin Madison Company Overview
    • 5.28.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview

6 Hearing Implants- Recent Developments

  • 6.1 Nov 02, 2020: Elos Medtech investing to meet increased demand in robotic surgery
  • 6.2 Oct 19, 2020: University of Sydney research could lead to customised cochlear implants
  • 6.3 Aug 06, 2020: Team to create customizable cochlear implant programming
  • 6.4 Jun 26, 2020: VISE researchers receive $3.1M grant for customizable cochlear implant programming
  • 6.5 May 19, 2020: Cochlear: Denial of appeal rehearing in US patent infringement case
  • 6.6 Mar 19, 2020: Federal Circuit affirms Alfred E. Mann Foundation's $268M win against Cochlear
  • 6.7 Feb 24, 2020: Intersect ENT reports fourth quarter and full year 2019 results
  • 6.8 Feb 18, 2020: AB initiates voluntary field corrective action - Strong performance of the Hearing Instruments business
  • 6.9 Feb 18, 2020: Elos Medtech - Year-end report, 1 January - 31 December, 2019
  • 6.10 Feb 18, 2020: AB initiates voluntary field corrective action - Strong performance of the Hearing Instruments business
  • 6.11 Jan 16, 2020: Audax Private Debt provides financing to support Olympus Partners Investment in Soliant Health
  • 6.12 Jan 13, 2020: Intersect ENT reports preliminary full year 2019 revenue
  • 6.13 Jan 10, 2020: Sonova announces changes to its Board of Directors
  • 6.14 Dec 12, 2019: Cochlear obtains FDA approval for bone conduction implant
  • 6.15 Dec 11, 2019: FDA clears Cochlear's innovative new Osia 2 hearing implant system
  • 6.16 Dec 10, 2019: Appointment of Michael Daniell to the Cochlear Limited Board

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Hearing Implants - Pipeline Products by Stage of Development
  • Table 2: Hearing Implants - Pipeline Products by Segment
  • Table 3: Hearing Implants - Pipeline Products by Territory
  • Table 4: Hearing Implants - Pipeline Products by Regulatory Path
  • Table 5: Hearing Implants - Pipeline Products by Estimated Approval Date
  • Table 6: Hearing Implants - Ongoing Clinical Trials
  • Table 7: Hearing Implants Companies - Pipeline Products by Stage of Development
  • Table 8: Hearing Implants - Pipeline Products by Stage of Development
  • Table 9: Advanced Bionics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Hires Fidelity 120 Pediatrics - Product Status
  • Table 11: Hires Fidelity 120 Pediatrics - Product Description
  • Table 12: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Steroid Eluting Cochlear Implant - Product Status
  • Table 14: Steroid Eluting Cochlear Implant - Product Description
  • Table 15: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Cerashield Coated Cochlear Inner Ear Implant - Product Status
  • Table 17: Cerashield Coated Cochlear Inner Ear Implant - Product Description
  • Table 18: Cochlear Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Status
  • Table 20: Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Description
  • Table 21: Nucleus Kanso 2 Sound Processor - Product Status
  • Table 22: Nucleus Kanso 2 Sound Processor - Product Description
  • Table 23: Nucleus Profile Plus - Product Status
  • Table 24: Nucleus Profile Plus - Product Description
  • Table 25: OSIA 2 System - Product Status
  • Table 26: OSIA 2 System - Product Description
  • Table 27: Cochlear Ltd - Ongoing Clinical Trials Overview
  • Table 28: OSIA 2 System - A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market
  • Table 29: Demant A/S Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Neuro 2 - Product Status
  • Table 31: Neuro 2 - Product Description
  • Table 32: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Soft Auditory Brainstem Implant - Product Status
  • Table 34: Soft Auditory Brainstem Implant - Product Description
  • Table 35: Envoy Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Acclaim Cochlear Implant - Product Status
  • Table 37: Acclaim Cochlear Implant - Product Description
  • Table 38: Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Optical Cochlea Stimulator - Product Status
  • Table 40: Optical Cochlea Stimulator - Product Description
  • Table 41: Hemideina Solution Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Hera Wireless Implant Device - Product Status
  • Table 43: Hera Wireless Implant Device - Product Description
  • Table 44: Huntington Medical Research Institutes Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Multisite Device - Product Status
  • Table 46: Multisite Device - Product Description
  • Table 47: iotaMotion Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Micro-Mechanical Insertion Tool - Product Status
  • Table 49: Micro-Mechanical Insertion Tool - Product Description
  • Table 50: Labyrinth Devices Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

List of Figures

  • Figure 1: Hearing Implants - Pipeline Products by Stage of Development
  • Figure 2: Hearing Implants - Pipeline Products by Segment
  • Figure 3: Hearing Implants - Pipeline Products by Territory
  • Figure 4: Hearing Implants - Pipeline Products by Regulatory Path
  • Figure 5: Hearing Implants - Pipeline Products by Estimated Approval Date
  • Figure 6: Hearing Implants - Ongoing Clinical Trials
Back to Top